Lexaria Bioscience Corp. 13D/A Filing - Ownership Update
Ticker: LEXX · Form: SC 13D/A · Filed: Aug 6, 2024
Sentiment: neutral
Topics: ownership-change, sec-filing, schedule-13d
Related Tickers: LEXX
TL;DR
Lexaria Bioscience Corp. 13D/A filed by Boos Wayne W. - ownership change.
AI Summary
On August 6, 2024, Lexaria Bioscience Corp. filed an amendment (No. 3) to its Schedule 13D. This filing relates to the acquisition of common stock by Boos Wayne W. The filing indicates a change in the ownership or control of a significant amount of Lexaria Bioscience Corp. securities.
Why It Matters
This filing signals a potential shift in control or significant stake-taking in Lexaria Bioscience Corp., which could impact its stock price and corporate strategy.
Risk Assessment
Risk Level: medium — Schedule 13D filings often indicate significant changes in beneficial ownership, which can lead to volatility and strategic shifts for the company.
Key Numbers
- 005-85256 — SEC File Number (Identifies the specific SEC filing for Lexaria Bioscience Corp.)
- 241179334 — Film Number (Internal SEC processing number for the filing.)
Key Players & Entities
- Lexaria Bioscience Corp. (company) — Subject Company
- Boos Wayne W (person) — Filing Person
- Robert B. Goldberg, Esq. (person) — Person Authorized to Receive Notices
FAQ
What is the specific date of the event requiring this Schedule 13D/A filing?
The date of the event which requires filing of this statement is July 31, 2024.
Who is the subject company in this filing?
The subject company is Lexaria Bioscience Corp.
What form is being filed?
The form being filed is SC 13D/A, an amendment to Schedule 13D.
Who is listed as the person authorized to receive notices and communications?
Robert B. Goldberg, Esq. is listed as the person authorized to receive notices and communications.
What is the CUSIP number for the class of securities?
The CUSIP number for Common Stock, Par Value $0.001 is 52886N.
Filing Details
This Form SC 13D/A (Form SC 13D/A) was filed with the SEC on August 6, 2024 by Boos Wayne W regarding Lexaria Bioscience Corp. (LEXX).